Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers

Clinical Hemorheology and Microcirculation

Volumn 60, Issue 3, 2015, Pages 309-316

  Caimi, G ^a   Ferrara, F ^a   Montana, M ^a   Muratori, I ^a   Amato, C ^a   Canino, B ^a   Lo Presti, R ^a   Hopps, E ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

MMP 2; MMP 9; TIMP 1; TIMP 2; Venous leg ulcers

Indexed keywords

COUMARIN; GELATINASE; GELATINASE A; GELATINASE B; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE; TIMP1 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN;

AGED; ARTICLE; BANDAGING TECHNIQUE; BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPRESSION; COMPRESSION THERAPY; CONTROLLED STUDY; ELISA KIT; EXTRACELLULAR MATRIX; FEMALE; HUMAN; LEG ARTERY; LEG ULCER; LEG VEIN; MALE; ULCER HEALING; VENOUS BLOOD; WOUND HEALING; BLOOD; METABOLISM; VARICOSE ULCER; VEIN INSUFFICIENCY;

AGED; FEMALE; GELATINASES; HUMANS; LEG ULCER; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VARICOSE ULCER; VENOUS INSUFFICIENCY;

EID: 84938571456     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-141863     Document Type: Article

References (33)

1. C. Amalinei, I.D. Caruntu and R.A. Balan, Biology of metalloproteinases, Rom J Morphol Embryol 48 (2007), 323-334.
2. B. Amato, G. Coretti, R. Compagna, M. Amato, G. Buffone, D. Gigliotti, R. Grande, R. Serra and S. de Franciscis, Role of matrix metalloproteinases in non-healing venous ulcers, Int Wound J (2013), in press.
3. R.L. Ashby, R. Gabe, S. Ali, U. Adderley, J.M. Bland, N.A. Cullum, J.C. Dumville, C.P. Iglesias, A.R. Kang'ombe, M.O. Soares, N.C. Stubbs and D.J. Torgerson, Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): A randomised controlled trial, Lancet (2013), in press.
4. S.K. Beidler, C.D. Douillet, D.F. Berndt, B.A. Keagy, P.B. Rich and W.A. Marston, Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy, J Vasc Surg 49 (2009), 1013-1020.
5. S.K. Beidler, C.D. Douillet, D.F. Berndt, B.A. Keagy, P.B. Rich and W.A. Marston, Multiplexed analysis of matrix metal-loproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy, Wound Repair Regen 16 (2008), 642-648.
6. D. Bourboulia and W.G. Stetler-Stevenson, Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion, Semin Cancer Biol 20 (2010), 161-168.
7. G. Caimi, B. Canino, F. Ferrara, M. Montana and R. Lo Presti, Leucocyte rheology at baseline and after activation in post-phlebitic syndrome, Phlebology 14 (1999), 100-104.
8. G. Caimi, B. Canino, F. Ferrara, M. Montana, F. Raimondi and R. LoPresti, Leukocyterheology beforeand after chemotactic activation in some venous diseases, Eur J Endovasc Surg 18 (1999), 411-416.
9. G. Caimi, M.G. Tozzi Ciancarelli, F. Ferrara, M. Montana, V. Calandrino, B. Canino and R. Lo Presti, Deep venous thrombosis: Behaviour of the polymorphonuclear leukocyte integrin pattern at baseline and after in vitro activation, Clinical Hemorheol Microcirc 33 (2005), 11-17.
10. M.M. Castro, A.D. Kandasamy, N. Youssef and R. Schulz, Matrix metalloproteinase inhibitor properties of tetracyclines: Therapeutic potential in cardiovascular diseases, Pharmacol Res 64 (2011), 551-560.
11. M.M. Castro, J.E. Tanus-Santos and R.F. Gerlach, Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension, Pharmacol Res 64 (2011), 567-572.
12. S.Y. Chuang, S.H. Yang, T.Y. Chen and J.H. Pang, Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells, Eur J Pharmacol 670 (2011), 419-426.
13. R. Deardorff and F.G. Spinale, Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure, Biomark Med 3 (2009), 513-523.
14. Y.Gu, H.M. Lee,T.Sorsa, A.Salminen, M.E. Ryan, M.J. Slepian and L.M. Golub, Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation, Pharmacol Res 64 (2011), 573-579.
15. S. Guo,M.Stins, M. Ning and E.H. Lo, Amelioration ofinflammation and cytotoxicityby dipyridamolein brain endothelial cells, Cerebrovasc Dis 30 (2010), 290-296.
16. Y. Herouy, D. Trefzer, U. Zimpfer, E. Schöpf, W. Wanscheidt and J. Norgauer, Matrix metalloproteinases and venous leg ulceration, Eur J Dermatol 10 (2000), 173-180.
17. A. Jaiswal, A. Chhabra, U. Malhotra, S. Kohli and V. Rani, Comparative analysis of human matrix metalloproteinases: Emerging therapeutic targets in diseases, Bioinformation 6 (2011), 23-30.
18. H.Lee, J.W. Park, S.P. Kim, E.H. Lo and S.R. Lee, Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia, Neurobiol Dis 34 (2009), 189-198.
19. R. Lo Presti, F. Ferrara, B. Canino, M. Montana and G. Caimi, Deep venous thrombosis: Leukocyte rheology at baseline and after in vitro activation, Haemostasis 30 (2000), 168-173.
20. R. Lo Presti, F. Ferrara, B. Canino, A. Valenti, F. Raimondi and G. Caimi, Fluiditá di membrana, calcio citosolico ed assetto integrinico dei leucociti polimorfonucleati in pazienti con ulcere venose, Minerva Cardioangiologica S1 (2006), 246-248.
21. F.J. Meyer, K.G. Burnand, S. Abisi, J.M. Tekoppele, B. van Els and A. Smith, Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers, Br J Surg 95 (2008), 319-325.
22. A.N. Moor, D.J. Vachon and L.J. Gould, Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers, Wound Repair Regen 17 (2009), 832-839.
23. B. Mwaura, B. Mahendran, N. Hynes, D. Defreitas, G. Avalos, T. Adegbola, M. Adham, C.E. Connolly and S. Sultan, The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers, Eur J Vasc Endovasc Surg 31 (2006), 306-310.
24. J. Norgauer, T. Hildenbrand, M. Idzko, E. Panther, E. Bandemir, M. Hartmann, W. Vanscheidt and Y. Herouy, Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers, Br J Dermatol 147 (2002), 1180-1186.
25. T.F. O'Donnell Jr and E.M. Balk, The need for an Intersociety Consensus Guideline for venous ulcer, J Vasc Surg 54 (2011), 83S-90S.
26. S. Saito, M.J. Trovato, R. You, B.K. Lal, F. Fasehun, F.T. Padberg Jr, R.W. Hobson 2nd, W.N. Durán and P.J. Pappas, Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency, J Vasc Surg 34 (2001), 930-938.
27. E. Scoditti, N. Calabriso, M. Massaro, M. Pellegrino, C. Storelli, G. Martines, R. De Caterina and M.A. Carluccio, Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer, Arch Biochem Biophys 527 (2012), 81-89.
28. R. Serra, G. Buffone, D. Falcone, V. Molinari, M. Scaramuzzino, L. Gallelli and S. de Franciscis, Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin, Wound Repair Regen 21 (2013), 395-401.
29. R. Serra, L. Gallelli, G. Buffone, V. Molinari, D.M. Stillitano, C. Palmieri and S. de Franciscis, Doxycycline speeds up healing of chronic venous ulcers, Int Wound J (2013), in press.
30. R. Serra, R. Grande, G. Buffone, V. Molinari, P. Perri, A. Perri, B. Amato, M. Colosimo and S. de Franciscis, Extracellular matrix assessment of infected chronic venous leg ulcers: Role of metalloproteinases and inflammatory cytokines, Int Wound J (2014), in press.
31. K. Subramaniam, C.M. Pech, M.C. Stacey and H.J. Wallace, Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid, Int Wound J 5 (2008), 79-86.
32. J.C. Tang, W.A. Marston and R.S. Kirsner, Wound Healing Society (WHS) venous ulcer treatment guidelines: What's new in five years? Wound Repair Regen 20 (2012), 619-637.
33. P. Zamboni, G. Scapoli, V. Lanzara, M. Izzo, P. Fortini, R. Legnaro, A. Palazzo, S. Tognazzo and D. Gemmati, Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers, Dermatol Surg 31 (2005), 644-649.